???global.info.a_carregar???
Ana Sofia Almeida Costa Nunes has concluded the PhD degree in Mechanisms of Disease and Regenerative Medicine in 2019/04/02 by Universidade do Algarve - Gambelas Campus and Nova medical School from Universidade Nova de Lisboa. She has published 4 original articles and 2 review articles in specialized journals, and published 4 book chapters.
Identification

Personal identification

Full name
Ana Sofia Almeida Costa Nunes

Citation names

  • Nunes, Sofia C.

Author identifiers

Ciência ID
0A1A-CA33-5100
ORCID iD
0000-0003-0802-7753

Languages

Language Speaking Reading Writing Listening Peer-review
English Intermediate (B1) Advanced (C1) Upper intermediate (B2) Intermediate (B1) Upper intermediate (B2)
Portuguese (Mother tongue)
Education
Degree Classification
2015/01/01 - 2019/04/02
Concluded
Mechanisms of Disease and Regenerative Medicine (Doutoramento)
Major in Oncobiology
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
"Cysteine, a facilitator of hypoxia adaptation and a promoter of drug-­-resistance-­- a new route to better diagnose and treat ovarian cancer patients" (THESIS/DISSERTATION)
Unanimously approved, Very Good, summa cum laude
2017/11/18
Concluded
Animal Assisted Therapy: dogs and horses (Pós-Graduação)
Instituto CRIAP, Portugal
18
2010/09 - 2012/11
Concluded
Evolutionary and Developmental Biology (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
18
2007/09 - 2010/09
Concluded
Biology (Licenciatura)
Universidade de Lisboa Faculdade de Ciências, Portugal
15
Outputs

Publications

Book chapter
  1. Nunes, Sofia C. (0A1A-CA33-5100). "Exploiting cancer cells metabolic adaptability to enhance therapy response in cancer". In Tumor microenvironment - the main driver of metabolic adaptation. Springer-Nature, 2020.
    Published
  2. Nunes, Sofia C (0A1A-CA33-5100); Serpa, Jacinta. "Recycling the interspecific relations with epithelial cells: bacteria and cancer metabolic symbiosis". In Tumor microenvironment - the main driver of metabolic adaptation. Springer-Nature, 2020.
    Published
  3. Nunes, Sofia C. (0A1A-CA33-5100). "Tumor microenvironment - selective pressures boosting cancer progression". In Tumor microenvironment - the main driver of metabolic adaptation. Springer-Nature, 2020.
    Published
  4. Carreira-Barbosa, Filipa; Nunes, Sofia C. (0A1A-CA33-5100). "Wnt signaling: paths for cancer progression". In Tumor microenvironment - the main driver of metabolic adaptation. Springer-Nature, 2020.
    Published
Conference abstract
  1. Felix, A; Silva, F; Ramos, C; Lopes-Coelho, F; Nunes, S; Serpa, J. "PO-468 Laminin332 (a3; ß3;¿2) genes and protein expression in cervical carcinomas". 2018.
    10.1136/esmoopen-2018-eacr25.975
  2. Nunes, Sofia C. (0A1A-CA33-5100); Cristiano Ramos; João B. Vicente; Sofia A. Pereira; Jacinta Serpa. "Enzymes involved in cysteine metabolism underlie hypoxia adaptation in ovarian cancer". Paper presented in 8th International Conference on Tumor Microenvironment: progression, therapy & Prevention, Lisbon, 2018.
Conference poster
  1. Ana Felix; Fernanda Silva; Cristiano Ramos; Filipa Lopes-Coelho; Sofia C. Nunes; Jacinta Serpa. "LAMININ332 (a3; ß3;¿2) genes and protein expression in cervical carcinomas". Paper presented in 25th Biennial Congress of the European Association for Cancer Research, 2018.
  2. Nunes, Sofia C. (0A1A-CA33-5100); Filipa Coelho; João B. Vicente; Ana Felix; Sofia A. Pereira; Jacinta Serpa. "Cysteine metabolism protects ovarian clear cell carcinoma (OCCC) cells in hypoxia". Paper presented in Cancer and Metabolism Conference, Cambridge, UK (Abcam), 2015.
  3. Nunes, S. (0A1A-CA33-5100); Dey, S.; Chelo, I.; Ferreira, A.; Teotónio, H.. "Population extinction and the role of standing diversity in experimental Caenorhabiditis elegans". Paper presented in X Encontro Nacional de Biologia Evolutiva, 2014.
  4. Dey, S.; Ibanez, P.; Nunes, A. S.; Proulx, S.; Teotónio, H.. "Adaptation to fluctuating anoxic environments in Caenorhabditis elegans. Evolutionary Biology of Caenorhabditis and other Nematodes". Paper presented in Evolutionary Biology of Caenorhabditis and other Nematodes, 2014.
Journal article
  1. Adriana Cruz; Pedro Mota; Cristiano Ramos; Rita F. Pires; Cindy Mendes; José P. Silva; Sofia C. Nunes; Vasco D.B. Bonifácio; Jacinta Serpa. "Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance". Antioxidants 9 2 (2020): 133. http://dx.doi.org/10.3390/antiox9020133.
    10.3390/antiox9020133
  2. Inês Santos; Cristiano Ramos; Cindy Mendes; Catarina O. Sequeira; Catarina S. Tomé; Dalila G.H. Fernandes; Pedro Mota; et al. "Targeting Glutathione and Cystathionine ß-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation". Nutrients (2019): http://dx.doi.org/10.3390/nu11102523.
    10.3390/nu11102523
  3. Nunes, Sofia C. (0A1A-CA33-5100); Serpa, Jacinta. "Glutathione in Ovarian Cancer: A Double-Edged Sword". International Journal of Molecular Sciences (2018): http://dx.doi.org/10.3390/ijms19071882.
    10.3390/ijms19071882
  4. Nunes, Sofia C.; Ramos, Cristiano; Lopes-Coelho, Filipa; Sequeira, Catarina O.; Silva, Fernanda; Gouveia-Fernandes, Sofia; Rodrigues, Armanda; et al. "Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity". Scientific Reports 8 1 (2018): http://dx.doi.org/10.1038/s41598-018-27753-y.
    10.1038/s41598-018-27753-y
  5. Nunes, SC; Lopes-Coelho, F; Gouveia-Fernandes, S; Ramos, C; Pereira, Sofia A; Serpa, J. "Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer". BMC Evolutionary Biology (2018): http://dx.doi.org/10.1186/s12862-018-1214-1.
    10.1186/s12862-018-1214-1
  6. Lopes-Coelho, F; Gouveia-Fernandes, S; Nunes, SC; Serpa, J. "Metabolic Dynamics in Breast Cancer: Cooperation between Cancer and Stromal Cells". J Clin Breast Cancer Res 1 (2017): 1001. https://pdfs.semanticscholar.org/f36c/b516eea94a3b1864b92f5bb88766087234a8.pdf.
    Published
Activities

Consulting

Activity description Institution / Organization
2019/07/19 - Current Medical Writing

Other jury / evaluation

Activity description Institution / Organization
2019/11/25 - Current Co-Editor of the Special Issue "New Therapies based on Cancer Metabolic Remodelling" in Molecules